The latest medical news, expert views on key health issues, as well as advice on disease prevention and management.
Blog
Multiparametric prostate MRI is a reliable tool in refining indications for biopsy
A study by Berlin scientists has convincingly shown that a negative multiparametric MRI of the prostate is reliable evidence of a very low risk of carcinoma development. If an experienced radiologist finds no signs of malignancy on such scans, regular follow-up can replace biopsy.
When should CDK4/6 inhibitors be used in breast cancer?
A Dutch study suggests that CDK4/6 inhibitors can be administered as second-line therapy in patients with advanced hormone-dependent and HER2-negative breast cancer without decreased survival, but with fewer side effects. The scientists reported about it in the journal Nature.
Pembrolizumab (Keytruda) may improve survival in triple-negative breast cancer
Patients with early-stage triple-negative breast cancer may benefit from supplementing chemotherapy with the administration of pembrolizumab. This was supported by the results of the phase 3 KEYNOTE-522 trial, published in the New England Journal of Medicine.
If your vision is at risk: modern treatments for retinal diseases
Vision is one of the most important senses that help humans find their way in the world around. About 80% of information comes to us through the eye, and the loss of this ability can seriously affect the quality of life, limiting the work performance, complicating daily activities and participation in social life.
A novel method of prostate cancer radiotherapy: maximum effect with minimal risks
Usually, in the case of a malignant tumor, the entire prostate is irradiated. However, modern imaging tools allow a gentler approach: targeting only the malignant focus.
Orthobiology: painless movements without scalpel and anesthesia
There have been many evolutionary changes in modern orthopaedics, but not so many truly revolutionary breakthroughs. Among the latter is the emergence of orthobiological methods for treating injuries and chronic musculoskeletal conditions.
New applications of sacituzumab govitecan for breast cancer
A large-scale study has shown that a drug approved for treatment of triple-negative breast cancer is also effective in metastasizing hormone-positive tumors.
A new endometriosis treatment option is available in Giessen
The growth of endometrium-similar tissue outside the womb causes severe pain. A procedure that helps to relieve women of one of the most troublesome endometriosis manifestations has been developed in Giessen (Germany).